Covered recipient · General Payments record
LINDSAY ELIZABETH KELLOGG
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$3,488.18
- Reported across 129 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $899.39 | 45 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $173.52 | 5 |
| PFIZER INC. | $55.00 | 3 |
| BeiGene USA, Inc. | $48.37 | 2 |
| ABBVIE INC. | $45.37 | 3 |
| Genentech USA, Inc. | $44.70 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.71 | 2 |
| Pharmacosmos Therapeutics Inc. | $36.21 | 2 |
| TAIHO ONCOLOGY, INC. | $35.51 | 2 |
| Astellas Pharma US Inc | $35.24 | 2 |
| GlaxoSmithKline, LLC. | $34.19 | 2 |
| AVEO Pharmaceuticals, Inc. | $25.52 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.85 | 1 |
| Adaptive Biotechnologies Corporation | $22.74 | 1 |
| Agios Pharmaceuticals, Inc. | $19.61 | 1 |
| Janssen Biotech, Inc. | $19.35 | 1 |
| Exelixis Inc. | $19.00 | 1 |
| Kyowa Kirin, Inc. | $18.76 | 1 |
| Lilly USA, LLC | $18.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.72 | 1 |
| Sumitomo Pharma America, Inc. | $18.00 | 1 |
| Daiichi Sankyo Inc. | $17.73 | 1 |
| ARRAY BIOPHARMA INC | $17.27 | 1 |
| SOBI, INC | $17.08 | 1 |
| Celgene Corporation | $16.78 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.59 | 1 |
| PharmaEssentia USA Corporation | $15.96 | 1 |
| ADC Therapeutics America, Inc. | $15.87 | 1 |
| Azurity Pharmaceuticals, Inc. | $15.77 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $13.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (45)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.